Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

Cancer Genetics Risk Assessment and Counseling (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf

PDF) Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Economic impact of multigene panel testing for hereditary breast and ovarian cancer

Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients, Genome Medicine

A new paradigm of genetic testing for hereditary breast/ovarian cancers

Prioritizing variants in complete Hereditary Breast and Ovarian Cancer (HBOC) genes in patients lacking known BRCA mutations

Familial Cancer Testing - Specialist Pathway

Mutational signatures for breast cancer diagnosis using artificial intelligence, Journal of the Egyptian National Cancer Institute

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

Early‐onset triple‐negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations - Liu - 2019 - Cancer Medicine - Wiley Online Library

Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India - ecancer